tissue-based diagnostics
Lung Cancer Study Suggests Liquid Biopsy Reduces Treatment Delays, Boosts Target Detection
A clinical trial suggests circulating tumor DNA genotyping prior to tissue-based diagnoses can reduce time to treatment in advanced NSCLC patients.
The company has published evidence that its TF estimation technique could potentially guide clinical follow-up decisions in cases with a negative liquid biopsy result.
Fulgent Genetics Preliminary Q1 Revenues Exceed Guidance; Firm to Acquire Inform Diagnostics
Fulgent plans to leverage the Texas-based pathology lab's established commercial organization and managed care relationships.
Qiagen, Mirati Therapeutics Partner to Develop KRAS Companion Test for NSCLC Drug
The tissue-based test will identify cancer patients who may benefit from adagrasib, Mirati's investigational oral small molecule inhibitor of KRAS G12C.
UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing
Premium
Spun out of the Glasgow Precision Oncology Laboratory, Gabriel wants targeted sequencing to become the norm for all somatic cancer patients.
May 13, 2020
Jul 25, 2019
Roche Reports Flat Diagnostics Revenues in H1
Apr 17, 2019
Roche Reports Flat Q1 Diagnostics Sales
Jan 19, 2018
Dec 23, 2014
Jun 23, 2014
Definiens Raises $20.4M in Private Financing Round
Jun 25, 2013
TGen, Ventana Ink Pancreatic Cancer Biomarker Pact
Feb 15, 2013
FDA Clears ASI Gene Scanner as PGx Tool for NSCLC
Feb 12, 2013
Dako, Pfizer Reach Companion Dx Deal
Sep 6, 2012